TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Hans Lennernäs Biomedical AB
Closing information (x1000 SEK)
| Closing information | 2025/06 | 2024/06 | 2023/06 |
| Turnover |
999
|
787
|
1,264 |
| Financial expenses |
53
|
110
|
444 |
| Earnings before taxes |
322
|
-115
|
98 |
| EBITDA |
370
|
-16
|
542 |
| Total assets |
14,480
|
14,554
|
15,047 |
| Current assets |
737
|
766
|
1,163 |
| Current liabilities |
151
|
256
|
390 |
| Equity capital |
14,267
|
14,232
|
14,547 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2025/06 | 2024/06 | 2023/06 |
| Solvency |
98.5%
|
97.8%
|
96.7% |
| Turnover per employee |
999
|
787
|
1,264 |
| Profit as a percentage of turnover |
32.2%
|
-14.6%
|
7.8% |
| Return on assets (ROA) |
2.6%
|
0.0%
|
3.6% |
| Current ratio |
488.1%
|
299.2%
|
298.2% |
| Return on equity (ROE) |
2.3%
|
-0.8%
|
0.7% |
| Change turnover |
212
|
-477
|
484 |
| Change turnover % |
27%
|
-38%
|
62% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/06 | 2024/06 | 2023/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.